Synthesis and anti-HIV activity of some novel 5-[ß-(10-phenothiazinyl)ethyl]-1-(acyl)-1,2,3,4-Tetrazoles

  • R Aiyalu
DOI: 10.4314/jpb.v4i1.32112
Keywords: HIV-1, Tetrazoles, Phenothaizines, CEM Cells

Abstract

Several 5-[ß-(10-phenothiazinyl)ethyl]-1-(acyl)-1,2,3,4-Tetrazoles have been synthesized and six of them were tested at the National Cancer Institute, Bethesada, Maryland, USA for their anti-HIV activity in susceptible human host cells (CEM Cell lines) over a wide range of concentrations from 6.36 x 10-8 to 2.00 x 10-4 M. (The highest protection observed is 112.84%). The most potent compound proved to be 5-[ß-(10-phenothiazinyl)ethyl]-1-(p-chlorobenzyl)-,2,3,4-Tetrazole (6) which displayed an EC50 of 3.45 x 10-6 M for inhibition of cytoprotective effect of HIV-1 in CEM cells. It exhibited cytotoxicity with an IC50 value of 6.25 x 10-5 M. The structure of these compounds has been established on the basis of elemental analysis and IR, 1H-NMR and Mass spectral data.

Keywords: HIV-1; Tetrazoles; Phenothaizines; CEM Cells

Journal of Pharmacy and Bioresources Vol. 4 (2) 2007: pp. 64-69
Published
2013-04-25
Issue
Vol. 4 No. 2 (2007)
Section
Articles

Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.

DECLARATION & COPYRIGHT TRANSFER

I/We the undersigned author(s) of article entitled

…………………………………………………………………………………………………………………

…………………………………………………………………………………………………………………

Declare as follows:

  1. The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
  2. The submitted manuscript is a joint decision of all the coauthors.
  3. Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
  4. Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
  5. Authors do not have any conflict of interest (financial or otherwise) other than those declared.
  6. If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.

 

Name & Signature of authors

       1.                                                                          2.

  1.                                                                          4.
  2.                                                                          6.
  3.                                                                          8.

 

Corresponding authors name address, affiliation and email:

Journal Identifiers


eISSN: 0189-8442